Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 12/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 10/20 | 0.51 |
| ▸ | SCD | O00767 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 5/20 | 0.46 |
| ▸ | CA1 | P00915 | 5/20 | 0.46 |
| ▸ | CA2 | P00918 | 5/20 | 0.46 |
| ▸ | CA9 | Q16790 | 5/20 | 0.46 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.45 |
| ▸ | MAP2K4 | P45985 | 1/20 | 0.45 |
| ▸ | DRD1 | P21728 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7780772 | 0.86 | PTGS2 (0.51) | PTGS2PTGS1SCDDRD1 | |
| SCHEMBL7777651 | 0.83 | CA1 (0.63) | PTGS2PTGS1CA12CA1CA2 | |
| SCHEMBL7779438 | 0.83 | CA1 (0.54) | PTGS2PTGS1CA12CA1CA2 | |
| SCHEMBL7780654 | 0.83 | PTGS2 (0.62) | PTGS2PTGS1MAP2K7MAP2K4 | |
| SCHEMBL8629397 | 0.82 | ALOX5AP (0.40) | SCDCA12CA1CA2CA9 | |
| SCHEMBL7779754 | 0.80 | MAP2K4 (0.51) | PTGS2PTGS1CA12CA1CA2 | |
| SCHEMBL7778071 | 0.79 | PTGS2 (0.53) | PTGS2PTGS1CA12CA1CA2 | |
| SCHEMBL4802143 | 0.78 | PTGS1 (0.73) | PTGS2PTGS1SCDCA12CA1 | |
| SCHEMBL7780061 | 0.78 | CA12 (0.56) | PTGS2PTGS1CA12CA1CA2 | |
| SCHEMBL7779676 | 0.78 | PTGS2 (0.53) | PTGS2PTGS1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0772597-B1 | 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2001-12-12 | — | — | EP | disclosed |
| EP-1127878-A1 | 3,4 - substituted pyrazoles for the treatment of inflammation | G.D. SEARLE & CO. (US) | 2001-08-29 | — | — | EP | disclosed |
| US-6028072-A | 3,4-substituted pyrazoles for the treatment of inflammation | G. D. SEARLE & CO. (US) | 2000-02-22 | — | — | US | disclosed |
| US-5580985-A | ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION | G. D. SEARLE & CO. (US) | 1996-12-03 | — | — | US | disclosed |
| US-5486534-A | 3,4-substituted pyrazoles for the treatment of inflammation | G. D. SEARLE & CO. (US) | 1996-01-23 | — | — | US | disclosed |